Clearside Biomedical Statistics Share Statistics Clearside Biomedical has 77.71M
shares outstanding. The number of shares has increased by 3.96%
in one year.
Shares Outstanding 77.71M Shares Change (YoY) 3.96% Shares Change (QoQ) 2.46% Owned by Institutions (%) 11.46% Shares Floating 61.36M Failed to Deliver (FTD) Shares 700 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 396.96K, so 0.51% of the outstanding
shares have been sold short.
Short Interest 396.96K Short % of Shares Out 0.51% Short % of Float 0.52% Short Ratio (days to cover) 1.8
Valuation Ratios The PE ratio is -2.04 and the forward
PE ratio is -0.67.
Clearside Biomedical's PEG ratio is
0.18.
PE Ratio -2.04 Forward PE -0.67 PS Ratio 42.14 Forward PS 0.4 PB Ratio -1.8 P/FCF Ratio -2.73 PEG Ratio 0.18
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Clearside Biomedical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.44,
with a Debt / Equity ratio of -0.02.
Current Ratio 4.44 Quick Ratio 4.44 Debt / Equity -0.02 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage -2.95
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $52K Profits Per Employee $-1.07M Employee Count 32 Asset Turnover 0.07 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -52.21% in the
last 52 weeks. The beta is 2.05, so Clearside Biomedical's
price volatility has been higher than the market average.
Beta 2.05 52-Week Price Change -52.21% 50-Day Moving Average 0.78 200-Day Moving Average 0.93 Relative Strength Index (RSI) 39.14 Average Volume (20 Days) 4,193,000
Income Statement In the last 12 months, Clearside Biomedical had revenue of 1.66M
and earned -34.35M
in profits. Earnings per share was -0.47.
Revenue 1.66M Gross Profit 1.51M Operating Income -28.88M Net Income -34.35M EBITDA -24.35M EBIT -24.57M Earnings Per Share (EPS) -0.47
Full Income Statement Balance Sheet The company has 20.02M in cash and 703K in
debt, giving a net cash position of 19.32M.
Cash & Cash Equivalents 20.02M Total Debt 703K Net Cash 19.32M Retained Earnings -355.27M Total Assets 19.67M Working Capital 10.95M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -24.7M
and capital expenditures -977K, giving a free cash flow of -25.68M.
Operating Cash Flow -24.7M Capital Expenditures -977K Free Cash Flow -25.68M FCF Per Share -0.35
Full Cash Flow Statement Margins Gross margin is 91.05%, with operating and profit margins of -1735.7% and -2064.42%.
Gross Margin 91.05% Operating Margin -1735.7% Pretax Margin -2064.42% Profit Margin -2064.42% EBITDA Margin -1463.16% EBIT Margin -1735.7% FCF Margin -1542.97%
